Browse studies

Find your next paid study

27,377 recruiting studies available now

Hypertonic Saline for Treatment of Pulmonary Mycobacterium Avium Complex (MAC) Disease

The MAC-HS study is a testing whether hypertonic saline helps improve symptoms and clearance of mycobacteria in patients with M. avium complex lung infections.

Nontuberculous Mycobacterial Lung DiseaseNontuberculous Mycobacterium Infection

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Oregon Health and Science UniversityNCT04921943

Phase 1

A Phase 1/2, Study to Evaluate the Safety, Tolerability, and Efficacy of One-time Intravitreal Dose of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

This is a sequential Phase 1/2, two-part, multicenter study on safety, tolerability, and efficacy of one-time intravitreal SAR446597 for the treatment of parti…

Geographic Atrophy

Estimated

~$150 – $4,500

Actual pay is set by the research site.

SanofiNCT07215234

Phase 1

Soy Tomato Juice to Improve Outcomes in Pancreatitis (the STOP Trial): a Phase 1/2 Single Arm Trial

This goal of this clinical trial is to see if people with recurrent acute pancreatitis or chronic pancreatitis can tolerate and regularly drink a tomato juice …

Recurrent Acute PancreatitisChronic Pancreatitis

Estimated

~$150 – $3,000

Actual pay is set by the research site.

Ohio State UniversityNCT07447687

Phase 2

PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study

This is a prospective, single-arm, open-label feasibility trial conducted at the MD Anderson Sarcoma Center and Cardio-Oncology Clinic. The study will enroll y…

Sarcoma,Soft Tissue

Estimated

~$75 – $2,000

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07874828

Phase 2

Cardioprotective Effects of Empagliflozin in Breast Cancer Patients Receiving Chemotherapy: A Pilot Study

The primary objective of this pilot study is to evaluate the feasibility and acceptability of a clinical trial protocol investigating 10 mg/day empagliflozin i…

Breast CancerSupportive Care in Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Virginia Commonwealth UniversityNCT07883512

Phase 2

A Randomized, Double-blind, Placebo-controlled Study Investigating the Effect of ALN-4324 on Insulin Sensitivity in Patients With Type 2 Diabetes Mellitus

The purpose of this study is to evaluate the effect of a single dose of ALN-4324 on whole-body insulin sensitivity in participants with T2DM

Type 2 Diabetes Mellitus (T2DM)

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Alnylam PharmaceuticalsNCT07465224

Observational

Exercise Testing for Neurological Conditions

The goal of this study is to investigate how a one-time exercise session influences different parameters of brain function in people with neurological diseases…

EpilepsyFunctional Neurological DisorderMild Cognitive Impairment+5 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Brigham and Women's HospitalNCT07883720

Phase 3

TRITON-CM: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Transthyretin-Mediated Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy)

The purpose of this study is to: * Evaluate the efficacy of nucresiran compared to placebo on reducing all-cause mortality and cardiovascular (CV) events * Ev…

Transthyretin Amyloidosis With Cardiomyopathy

Estimated

~$50 – $2,100

Actual pay is set by the research site.

Alnylam PharmaceuticalsNCT07052903

Phase 2

Phase 2 Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Not Achieving Glycemic Targets Despite GLP-1-Based Therapy

This is a phase 2 randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes (T2D)…

Type 2 Diabetes

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Biomea Fusion Inc.NCT07502508

Observational

Quantifying Motor Network Dynamics to Predict and Enhance Outcomes in Pediatric Dystonia

The goal of this study is to understand the development and progression of childhood dystonia, a movement disorder, in children. The main questions it aims to …

DystoniaPediatricDeep Brain Stimulation+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

Children's Hospital Medical Center, CincinnatiNCT07325175

Observational

Comparative Efficacy, Safety, and Efficiency of SYSTEM 1 Versus SYSTEM 2 Pulse Field Ablation Systems for Atrial Fibrillation Ablation Randomized Controlled Trial

This study randomizes patients undergoing PFA for A Fib to one of two standard care PFA systems. The patient will have an ICM placed to continuously monitor th…

AF - Atrial Fibrillation

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT07883629

Phase 2

Bexmarilimab Plus Azacitidine in a Randomized, Double-blind, Placebo-controlled Phase IIb Trial in Treatment-naïve Higher-risk Myelodysplastic Syndromes (HR-MDS)

This Phase IIb study (BEXERA) will evaluate the safety and efficacy of bexmarilimab (FP-1305), an antibody targeting Clever-1, given in combination with azacit…

Higher Risk Myelodysplastic Syndromes

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Faron Pharmaceuticals LtdNCT07672769